Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Poire, Xavier" or (type any "bookEditor journalEditor issueEditor" and editor="Poire, Xav...

Add to list
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Anke Delie (UGent) , Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure (UGent) , Frederic Baron, Dimitri Breems, Ann De Becker, Carlos Graux, Philippe Lewalle, et al.

(2021) ACTA CLINICA BELGICA.
Add to list
- Journal Article
- A1
- open access
Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies : an update of the pivotal clinical trial data

Gils Roex, Tom Feys, Yves Beguin, Tessa Kerre (UGent) , Xavier Poire, Philippe Lewalle, Peter Vandenberghe, Dominique Bron and Sebastien Anguille

(2020) PHARMACEUTICS. 12(2).
Add to list
- Conference Paper
Results from the Phase I Clinical Studies Evaluating Cyad-01, a First-Generation NKG2D CAR T-Cell Product in Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

David A. Sallman, A. Samer Al-Homsi, Marco L. Davila, Tessa Kerre (UGent) , Ine Moors (UGent) , Xavier Poire, Violaine Havelange, Philippe Lewalle, Daniel A. Pollyea, Eunice S. Wang, et al.

(2020) BLOOD. 136.
Add to list
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients : a report from the EBMT Severe Aplastic Anemia Working Party

Pedro H. Prata, Dirk-Jan Eikema, Boris Afansyev, Paul Bosman, Frans Smiers, Jose L. Diez-Martin, Celso Arrais-Rodrigues, Yener Koc, Xavier Poire, Anne Sirvent, et al.

(2020) BONE MARROW TRANSPLANTATION. 55(6). p.1050-1058
Add to list
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia following total body irradiation : the effect of anti-thymocyte globulin on transplant outcome : ALWP of the EBMT study

Arnon Nagler, Myriam Labopin, Riitta Niittyvuopio, Johan Maertens, Xavier Poire, Jan Cornelissen, Peter Remenyi, Jean Henri Bourhis, Yves Beguin, Charles Craddock, et al.

(2019) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. In Biology of Blood and Marrow Transportation 25(3). p.S187-S187
Add to list
- Conference Paper
- C3
- open access
Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients

David A. Sallman, Jason B. Brayer, Xavier Poire, Violaine Havelange, Ahmad Awada, Philippe Lewalle, Kunle Odunsi, Eunice S. Wang, Caroline Lonez, Thomas Lequertier, et al.

(2019) BLOOD. In Blood 134(Supplement 1).
Add to list
- Journal Article
- A1
- open access
Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Riitta Niittyvuopio, Johan Maertens, Xavier Poire, Jan Cornelissen, Peter Remenyi, Jean Henri Bourhis, Yves Beguin, et al.

(2019) BLOOD ADVANCES. 3(13). p.1950-1960
Add to list
- Conference Paper
- C3
Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study

Sophie Servais, Frederic Baron, Chantal Lechanteur, Etienne Baudoux, Alexandra Briquet, Dominik Selleslag, Johan A. Maertens, Xavier Poire, Wilfried Schroyens, Carlos Graux, et al.

(2019) BLOOD. 134(Suppl 1).
Add to list
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

Helene A. Poirel, Marijke Vanspauwen, Gilles Macq, Anke De Geyndt, Johan Maertens, Evelyne Willems, Dominik Selleslag, Xavier Poire, Koen Theunissen, Carlos Graux, et al.

(2019) BONE MARROW TRANSPLANTATION. 54(9). p.1434-1442
Add to list
- Conference Paper
- C3
Early signs of clinical activity in Aml patients receiving NKG2D CAR T cell therapy in the absence of pre-conditioning chemotherapy : an alternative strategy to CAR T cell therapy

Eytan Breman, David A Sallman, Jason B Brayer, Xavier Poire, Tessa Kerre (UGent) , Philippe Lewalle, Eunice S Wang, Bikash Verma, Marco L Davila, Nathalie Braun, et al.

(2018) MOLECULAR THERAPY. 26(5, suppl. 1). p.440-440

Academic Bibliography

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies : an update of the pivotal clinical trial data

Results from the Phase I Clinical Studies Evaluating Cyad-01, a First-Generation NKG2D CAR T-Cell Product in Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients : a report from the EBMT Severe Aplastic Anemia Working Party

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia following total body irradiation : the effect of anti-thymocyte globulin on transplant outcome : ALWP of the EBMT study

Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

Early signs of clinical activity in Aml patients receiving NKG2D CAR T cell therapy in the absence of pre-conditioning chemotherapy : an alternative strategy to CAR T cell therapy

Contents

Support

Contact